X-ray Activated TiO2 Nanoparticles for Deep Tumor Photocatalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer treatments using photocatalytic therapy with UV light face limitations such as non-biocompatibility, limited light penetration, and unsuitability for larger or irregular tumors, necessitating the exploration of alternative radiation sources for enhanced efficacy.

Innovation Solution

Introducing semiconductor nanoparticles like titanium oxide, encapsulated with surface materials and modified with transition metals, into biological entities and irradiating them with X-rays to induce photocatalytic effects, leveraging the deep penetration and focusing capabilities of synchrotron X-ray irradiation to produce oxidative radicals and kill cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If UV light is used for photocatalytic cancer therapy, then photocatalytic effect is achieved, but biocompatibility is poor and light penetration is limited

Engineering Contradiction:
Improvephotocatalytic effectVSAvoidbiocompatibility and light penetration
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the wavelength parameter of irradiation from UV to X-ray range, enabling deeper tissue penetration while maintaining photocatalytic activity of TiO2 nanoparticles. This parameter shift resolves the contradiction between achieving photocatalytic effect and ensuring biocompatibility with adequate light penetration.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

TiO2 nanoparticles serve as an intermediary that absorbs X-ray energy and converts it to catalytic activity, mediating between the X-ray source and cancer cells. This intermediary enables indirect photocatalytic action that overcomes the limitations of direct UV illumination.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If TiO2 nanoparticles are used for photocatalytic therapy, then cancer cell killing efficacy is achieved, but suitability for larger and irregular tumors is limited

Engineering Contradiction:
Improvecancer cell killing efficacyVSAvoidsuitability for larger and irregular tumors
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

Changing the irradiation wavelength to X-ray range enables deeper penetration into larger and irregular tumor masses, making the therapy adaptable to various tumor sizes and shapes while maintaining cell killing efficacy through photocatalytic activation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

X-ray induced photocatalytic effects with TiO2 nanoparticles demonstrate enhanced cancer cell killing efficacy compared to UV illumination, with gold-modified nanoparticles showing improved performance, suitable for treating various tumor types and potentially applicable in bioimaging and drug delivery.

Implementation Method 1

Photocatalysis, as the name suggests, refers to catalysis under light irradiation. The most important process is photo-induced charge separation and subsequent dark catalyses by the positive and negative charges.

Methodology Applied
Scientific EffectPhotocatalysis: Catalysis

Implementation Method 2

The most important process is photo-induced charge separation and subsequent dark catalyses by the positive and negative charges.

Methodology Applied
Scientific EffectPhoto-induced charge separation: Photoelectric Effect

Implementation Method 3

A. Fujishima and K. Honda firstly discovered in 1972 that UV light can induce water cleavage in the presence of TiO2

Methodology Applied
Scientific EffectRadiolysis: Photodissociation

Data Source

PatentUS9474769B2Methods of treating cancers
Publication Date: 2016.10.25 HWU YEU KUANG
  • US9474769B2 patent drawing
  • US9474769B2 patent drawing
  • US9474769B2 patent drawing

AI summary

A method of treating cancer. The method includes introducing an effective amount of an oxidative catalyzing agent including titanium oxide, zinc oxide, zirconium oxide, tungsten oxide or tin oxide into a biological entity, and irradiating the biological entity with a ray. The oxidative catalyzing agent produces hydroxyl or hydrogen peroxide radicals after irradiation with the ray thereon.